Key facts
- This page summarizes Russell T. Ray's Form 4 filing for MERRIMACK PHARMACEUTICALS INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2022, 15:05.
Russell T. Ray - 31 Dec 2021 Form 4 Insider Report for MERRIMACK PHARMACEUTICALS INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 31 Dec 2021
- Net transaction value
- -$3,840
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2022, 15:05:24 UTC
- Prior SEC filing
- 05 Aug 2021
- Next SEC filing
- 18 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Russell T. Ray
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Russell T. Ray filed Form 4 for MERRIMACK PHARMACEUTICALS INC on 04 Jan 2022.
Change
- Previous filing in this sequence was filed on 05 Aug 2021.
- Current net transaction value: -$3,840.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MACK
transaction
Common Stock
Sale
- Transaction value
- $3,840
- Shares
- -1,000
- Change %
- -100%
- Price
- $3.84
- Shares after
- 0
- Date
- 31 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.